20,020,657 12,264,536
Advances to suppliers 4,900,335 4,309,352
Notes receivable 1,020,944 2,259,616
Refundable deposit 16,447,719 -
Other current assets 4,960,413 5,134,118
Total Current Assets 220,728,906 206,872,316
LONG-TERM ASSETS
Plant and equipment, net 49,889,005 48,496,760
Land use rights, net 47,962,086 46,310,240
Construction in progress 734,694 755,614
Deferred tax assets 1,735,743 1,498,481
Other intangible assets, net 26,833,875 26,972,166
Goodwill 22,566,767 22,566,768
Long-term investment and advance 249,481 242,551
Total Long-Term Assets 149,971,651 146,842,580
TOTAL ASSETS $370,700,557 $353,714,896
AMERICAN ORIENTAL BIOENGINEERING, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
LIABILITIES AND SHAREHOLDERS' EQUITY
MARCH 31, DECEMBER 31,
2008 2007
UNAUDITED
CURRENT LIABILITIES
Accounts payable $4,041,111 $3,436,352
Other payables and accrued expenses 5,367,646 7,786,157
Taxes payable 2,203,855 2,843,719
Short-term bank loans 6,550,654 6,289,222
Current portion of long-term bank loans 2,89
'/>"/>
SOURCE American Oriental Bioengineering Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related biology technology :1.
LifeQuest World Launches Immune System Boosting Supplement to the North American Market2.
American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health3.
YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING4.
Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research5.
American Oriental Bioengineering to Report First Quarter 2008 Financial Results6.
FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data to the American Association for Cancer Research7.
Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research8.
SPO Medical Retains American Capital Ventures for Investor Relations Services9.
NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect 10.
Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting11.
American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance